Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S H Bell

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Southern Medical Journal|August 7, 2010
Goals for HbA1c need to be individualized based on clinical judgment, instead of third party recommendationsDavid S H Bell
Southern Medical Journal|February 7, 2002
Chronic complications of diabetesDavid S H Bell
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 15, 2003
Why I initiate therapy with two insulin sensitizers in patients with type 2 diabetesDavid S H Bell
The American Journal of Medicine|March 17, 2004
Type 2 diabetes mellitus: what is the optimal treatment regimen?David S H Bell
The American Journal of Medicine|December 18, 2003
Beta-cell rejuvenation with thiazolidinedionesDavid S H Bell
The American Journal of Cardiology|May 18, 2004
Advantages of a third-generation beta-blocker in patients with diabetes mellitusDavid S H Bell
Medgenmed : Medscape General Medicine|January 14, 2005
Advances in diabetes for the millennium: the heart and diabetesDavid S H Bell
Treatments in Endocrinology|March 4, 2005
A comparison of agents used to manage type 2 diabetes mellitus: need for reappraisal of traditional approachesDavid S H Bell
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 18, 2006
Do sulfonylurea drugs increase the risk of cardiac events?David S H Bell
Current Medical Research and Opinion|August 9, 2005
Optimizing treatment of diabetes and cardiovascular disease with combined alpha,beta-blockadeDavid S H Bell
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Southern Medical Journal|August 7, 2010
Goals for HbA1c need to be individualized based on clinical judgment, instead of third party recommendationsDavid S H Bell
Southern Medical Journal|February 7, 2002
Chronic complications of diabetesDavid S H Bell
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 15, 2003
Why I initiate therapy with two insulin sensitizers in patients with type 2 diabetesDavid S H Bell
The American Journal of Medicine|March 17, 2004
Type 2 diabetes mellitus: what is the optimal treatment regimen?David S H Bell
The American Journal of Medicine|December 18, 2003
Beta-cell rejuvenation with thiazolidinedionesDavid S H Bell
The American Journal of Cardiology|May 18, 2004
Advantages of a third-generation beta-blocker in patients with diabetes mellitusDavid S H Bell
Medgenmed : Medscape General Medicine|January 14, 2005
Advances in diabetes for the millennium: the heart and diabetesDavid S H Bell
Treatments in Endocrinology|March 4, 2005
A comparison of agents used to manage type 2 diabetes mellitus: need for reappraisal of traditional approachesDavid S H Bell
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 18, 2006
Do sulfonylurea drugs increase the risk of cardiac events?David S H Bell
Current Medical Research and Opinion|August 9, 2005
Optimizing treatment of diabetes and cardiovascular disease with combined alpha,beta-blockadeDavid S H Bell
Pageof 13